Baseline characteristics at the time of ARL diagnosis
Characteristics . | Data . |
|---|---|
| No. patients studied | 89 |
| No. men/no. women | 82/7 |
| Age, y, mean ± SD (range) | 40.9 ± 9.9 (23.0-69.1) |
| Localization of ARL, no. (%) | |
| At least 1 extranodal manifestation | 63 (71) |
| Strictly nodal manifestation | 26 (29) |
| Ann Arbor stage, no. (%) | |
| I-II | 25 (28) |
| III-IV | 61 (69) |
| No staging available | 3 (3) |
| B symptoms | 53 (63) |
| Modified age adjusted IPI score, no. (%) | |
| Low IPI of 0 or 1 | 28 (31) |
| High IPI of 2 or 3 | 51 (57) |
| No IPI available | 10 (11) |
| Immunologic, virologic, and other parameters | |
| Prior AIDS diagnosis, no. (%) | 27 (31) |
| Absolute CD4 cell counts, cells/μL, mean ± SD (range) | 201 ± 198 (0-960) |
| Viral load, log copies/mL, mean ± SD (range) | 4.57 ± 1.45 (0.90-6.43) |
| Elevated LDH, no. (%) | 53 (65) |
| Hemoglobin level, g/dL, mean ± SD (range) | 12.2 ± 2.2 (7.2-17.3) |
Characteristics . | Data . |
|---|---|
| No. patients studied | 89 |
| No. men/no. women | 82/7 |
| Age, y, mean ± SD (range) | 40.9 ± 9.9 (23.0-69.1) |
| Localization of ARL, no. (%) | |
| At least 1 extranodal manifestation | 63 (71) |
| Strictly nodal manifestation | 26 (29) |
| Ann Arbor stage, no. (%) | |
| I-II | 25 (28) |
| III-IV | 61 (69) |
| No staging available | 3 (3) |
| B symptoms | 53 (63) |
| Modified age adjusted IPI score, no. (%) | |
| Low IPI of 0 or 1 | 28 (31) |
| High IPI of 2 or 3 | 51 (57) |
| No IPI available | 10 (11) |
| Immunologic, virologic, and other parameters | |
| Prior AIDS diagnosis, no. (%) | 27 (31) |
| Absolute CD4 cell counts, cells/μL, mean ± SD (range) | 201 ± 198 (0-960) |
| Viral load, log copies/mL, mean ± SD (range) | 4.57 ± 1.45 (0.90-6.43) |
| Elevated LDH, no. (%) | 53 (65) |
| Hemoglobin level, g/dL, mean ± SD (range) | 12.2 ± 2.2 (7.2-17.3) |
ARL indicates AIDS-related lymphoma; IPI, International Prognostic Score; LDH, lactate dehydrogenase.